Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to 0.52.

  • Cellebrite DI's Equity Ratio rose 601.67% to 0.52 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.52, marking a year-over-year increase of 601.67%. This contributed to the annual value of 0.52 for FY2025, which is 601.67% up from last year.
  • Cellebrite DI's Equity Ratio amounted to 0.52 in Q4 2025, which was up 601.67% from 0.49 recorded in Q4 2024.
  • Cellebrite DI's Equity Ratio's 5-year high stood at 0.52 during Q4 2025, with a 5-year trough of 0.41 in Q3 2021.
  • For the 5-year period, Cellebrite DI's Equity Ratio averaged around 0.09, with its median value being 0.07 (2022).
  • Per our database at Business Quant, Cellebrite DI's Equity Ratio plummeted by 22328.09% in 2021 and then skyrocketed by 65790.42% in 2024.
  • Over the past 5 years, Cellebrite DI's Equity Ratio (Quarter) stood at 0.22 in 2021, then soared by 184.85% to 0.18 in 2022, then plummeted by 64.95% to 0.06 in 2023, then surged by 657.9% to 0.49 in 2024, then rose by 6.02% to 0.52 in 2025.
  • Its Equity Ratio stands at 0.52 for Q4 2025, versus 0.49 for Q4 2024 and 0.06 for Q4 2023.